Envoy Medical Inc.
COCH | NASDAQ
$0.72
+$0.01 (+1.34%)
Sep 22, 2026, 12:35 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.54 | -0.96 | -0.71 | -6.38 | -9.28 | -840.6K |
PEG Ratio | 0.03 | 0.02 | -0.01 | -0.13 | n/a | n/a |
PS Ratio | 63.80 | 119.42 | 71.93 | 429.30 | 319.03 | n/a |
PB Ratio | -1.31 | -1.43 | -12.80 | -2.81 | -2.20 | 24.25K |
P/FCF Ratio | -0.84 | -1.42 | -1.32 | -11.28 | -14.01 | n/a |
P/OCF Ratio | -0.84 | -1.50 | -1.33 | -11.56 | -14.26 | n/a |
OCF/S Ratio | -7.55K | -7.98K | -5.41K | -3.72K | -2.24K | n/a |
Debt / Equity Ratio | -0.08 | -1.04 | -0.32 | -0.95 | -0.52 | n/a |
Quick Ratio | 0.41 | 1.02 | 0.83 | 0.14 | 0.99 | 0.26 |
Current Ratio | 0.54 | 1.24 | 1.02 | 0.65 | 1.76 | 0.26 |
Asset Turnover | 0.03 | 0.02 | 0.04 | 0.09 | 0.12 | n/a |
Interest Coverage | -14.01 | -23.60 | n/a | n/a | n/a | n/a |
Return on Equity | 201.89% | 110.37% | 1.68K% | 43.99% | 19.29% | -2.88% |
Return on Assets | -277.59% | -180.23% | -361.77% | -622.97% | -330.60% | -0.58% |
Return on Invested Capital | 786.93% | -464.78% | -1.6K% | -1.43K% | -554.11% | -2.88% |
Dividend Yield | 11.83% | 9.11% | n/a | n/a | n/a | n/a |
Payout Ratio | -7.66% | -11.77% | n/a | n/a | n/a | n/a |
FCF Payout Ratio | -9.85% | -12.93% | n/a | n/a | n/a | n/a |
Gross Profit Margin | -262.66% | -229.78% | -149.68% | -110.13% | -148.06% | n/a |
Net Profit Margin | -9.86K% | -9.24K% | -9.47K% | -6.72K% | -2.8K% | n/a |
Pretax Profit Margin | -9.86K% | -9.24K% | -9.47K% | -6.72K% | -2.8K% | n/a |
Operating Profit Margin | -9.24K% | -8.56K% | -5.81K% | -3.67K% | -2.22K% | n/a |
FCF Margin | -7.63K% | -8.41K% | -5.46K% | -3.81K% | -2.28K% | n/a |
EBITDA Margin | -9.07K% | -8.8K% | -9.43K% | -6.69K% | -2.78K% | n/a |
Add to Watchlist
Select watchlists to add or remove COCH